Actively Recruiting
Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
Led by Ali Chappell · Updated on 2026-05-01
150
Participants Needed
1
Research Sites
199 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to investigate the relationship between fasting insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) across various demographic factors, including age, sex, race/ethnicity, BMI, and polycystic ovary syndrome (PCOS) diagnosis. By analyzing these variables, the study seeks to identify potential variations in insulin levels, which could provide valuable insights into the impact of different factors on metabolic health and the development of insulin-related conditions.
CONDITIONS
Official Title
Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants aged 18 or older
- Both males and females
- Participants from diverse racial and ethnic backgrounds
- Participants across a range of body mass index (BMI) values
- Participants with and without a confirmed diagnosis of PCOS based on established diagnostic criteria
- Completion of metabolic testing within one month prior to enrollment, including fasting insulin, hemoglobin A1c, complete lipid panel, and triglycerides
- Laboratory testing completed through a healthcare provider, independent laboratory, or using an Insara Insulin Testing Kit
- Laboratory values obtained following a minimum 8-hour fast
- Complete laboratory data available for all required measures
You will not qualify if you...
- Participants under 18 years of age
- Presence of other endocrine disorders affecting insulin levels (e.g., insulin-secreting tumors)
- Recent weight loss exceeding 5% of body weight within the previous month
- Pregnancy or breastfeeding
- Acute illness or infection within the past 2 weeks
- Use of medications known to significantly affect insulin or glucose metabolism (these will be recorded and considered in analysis)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Lilli Health
Houston, Texas, United States, 77554
Actively Recruiting
Research Team
A
Ali M Chappell, PhD, MS, RD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here